| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Apr 3, 2018 | Apr 3, 2018 | Cogent Biosciences, Inc. | 10% Owner | Buy | 92.5 | +94,052 | 2.88% | ✗ | $1.1M |
| Jul 7, 2017 | Jul 11, 2017 | Intellia Therapeutics, Inc. | 10% Owner | Sell | 17.5 | -150,000 | -4.02% | ✗ | $2.4M |